๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Malignant Tumor of Liver

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection NCT06219096NA1 site๐Ÿ“ Chengdu West China Hospital ยท Tests: NIF image-guided laparoscopic anatomical liver resection with the novel ICG@HSA administration, NIF image-guided laparoโ€ฆ Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging NCT06060769n/a1 site๐Ÿ“ Zhuhai Fifth Affiliated Hospital, Sun Yat-Sen University Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance NCT06653062n/a1 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Plasma and Tumor Tissue Mitochondrial DNA (mtDNA) Mutation Analysis A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites๐Ÿ“ San Francisco๐Ÿ“ Walnut Creek University of California, San Francisco ยท Tests: Radiation Therapy (RT) Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Shanghai GV20 Therapeutics ยท Tests: GV20-0251 A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Sarasota๐Ÿ“ St Louis Angiex, Inc. ยท Tests: AGX101 A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab JMT106 Injection in the Treatment of Advanced Solid Tumors NCT07275073Phase 11 site๐Ÿ“ Zhejiang Shanghai JMT-Bio Inc. ยท Tests: JMT106 Injection A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors NCT06533332Phase 15 sites๐Ÿ“ Ryde๐Ÿ“ Sydney๐Ÿ“ Westmead EtiraRx Australia Pty Ltd ยท Tests: ERX-315 Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach๏ผˆRadiogenomics-Liver๏ผ‰ NCT06536998n/a1 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor NCT04906434Phase 132 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Tampa Abbisko Therapeutics Co, Ltd ยท Tests: ABSK-011 Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis NCT06166576Phase 25 sites๐Ÿ“ Ilsan๐Ÿ“ Seongnam-si๐Ÿ“ Seoul Seoul National University Hospital ยท Tests: Ablative radioembolization A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer NCT06636435Phase 15 sites๐Ÿ“ Kashiwa๐Ÿ“ Yokohama๐Ÿ“ Niigata Chiome Bioscience Inc. ยท Tests: CBA-1205 Part 1, CBA-1205 Part 2, CBA-1205 Part 3, CBA-1205 Part 4, CBA-1205 Part 5 Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors NCT04803318Phase 21 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Combination of three inhibitors Trametinib, Everolimus and Lenvatinib Molecular Basis of Pediatric Liver Cancer NCT03959800n/a1 site๐Ÿ“ Pittsburgh University of Pittsburgh Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies NCT07459309NA1 site๐Ÿ“ Shanghai Fudan University ยท Tests: Multimodal Tumor Thermal Ablation TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer NCT06532799Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine, Interleukin-2, Pembrolizumab Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients NCT05068531n/a1 site๐Ÿ“ Montreal Centre hospitalier de l'Universitรฉ de Montrรฉal (CHUM) A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) NCT05098197EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Juncell Therapeutics ยท Tests: Tumor Infiltrating Lymphocyte Evaluation of Resection Techniques for Pancreatic Tumors NCT05128890n/a1 site๐Ÿ“ Dallas Methodist Health System ยท Tests: Resection techniques for pancreatic and liver tumors COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases NCT06185556Phase 2, Phase 31 site๐Ÿ“ Amsterdam Amsterdam UMC, location VUmc ยท Tests: Irreversible electroporation, Stereotactic body radiotherapy A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors NCT07317505Phase 13 sites๐Ÿ“ Huntersville๐Ÿ“ Dallas๐Ÿ“ Fairfax Conjupro Biotherapeutics, Inc. ยท Tests: JMT108 Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma NCT06383520EARLY Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: 68Ga-aGPC3-scFv/Fab Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective Trial NCT07847359Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Cryoablation, Iparomlimab and Tuvonralimab, Dacarbazine, Lenvatinib Early Detection of Advanced Adenomas and Colorectal Cancer NCT06342440n/a6 sites๐Ÿ“ Monrovia๐Ÿ“ San Diego๐Ÿ“ Dalian City of Hope Medical Center ยท Tests: DENEB Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Tissue Collection Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus NCT07776080Phase 21 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: Iparomlimab and Tuvonralimab (QL1706), Lenvatinib, Radiotherapy, hepatic arterial infusion chemotherapy (HAIC)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy